-+ 0.00%
-+ 0.00%
-+ 0.00%

Vigonvita Life Sciences wins Hong Kong listing approval for 100,220,667 converted H shares under full circulation plan

PUBT·07/06/2026 00:01:10
Listen to the news
Vigonvita Life Sciences wins Hong Kong listing approval for 100,220,667 converted H shares under full circulation plan
  • Vigonvita Life Sciences received Hong Kong listing approval on July 3, 2026 for 100,220,667 converted H shares.
  • The conversion covers unlisted shares held by 10 shareholders, shifting most of the register into tradable H shares.
  • Post-conversion, H shares rise to 166,897,800, representing 99.58% of issued share capital; domestic unlisted shares fall to 700,000.
  • The company will now complete the conversion procedures, with further updates planned as the process advances.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vigonvita Life Sciences Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260706-12233092), on July 06, 2026, and is solely responsible for the information contained therein.